
Loading, please wait...

Loading, please wait...

Union Health Minister J P Nadda inaugurated the advanced ARHI Hospital in Meghalaya's Ri-Bhoi district on Thursday. During the event, he reaffirmed the Central Government's commitment to strengthening Northeast healthcare infrastructure. Consequently, local patients will no longer need to travel to distant states for critical medical diagnoses. Additionally, this facility aims to bridge the long-standing gap in tertiary care accessibility for remote and underserved areas in the region.
The newly established 120-bed super-specialty hospital, located strategically in Jorabat, features state-of-the-art medical technologies. Specifically, the hospital boasts a comprehensive oncology unit, PET-CT scan services, and a modern Neonatal Intensive Care Unit (NICU). Furthermore, six modular operation theatres are available to handle diverse surgical procedures. Historically, patients from Meghalaya's hilly districts faced significant challenges due to limited local healthcare services. Therefore, the introduction of high-end diagnostic tools represents a major shift that will save valuable time and reduce financial burdens.
Addressing the gathering, Minister Nadda emphasized that the facility perfectly aligns with India's National Health Policy 2017. He explained how this national framework aims to robustly support healthcare delivery from grassroots sub-centers to tertiary hospitals. Moreover, the government's 'Act East' policy has catalyzed medical development across the entire region. Because of these strategic initiatives, local healthcare systems are experiencing unprecedented expansion and improvement. Ultimately, the government intends to establish sustainable medical hubs closer to patients' homes.
Q1: What major healthcare facility was recently inaugurated in Meghalaya?
Union Health Minister J P Nadda inaugurated ARHI Hospital, a modern 120-bed super-specialty tertiary care institution in Ri-Bhoi district, Meghalaya.
Q2: What medical specialties and services does ARHI Hospital offer?
The hospital offers comprehensive oncology care, PET-CT imaging, critical care facilities, a Neonatal Intensive Care Unit (NICU), and six modular operation theatres.
Q3: How does this new facility benefit patients in the region?
It provides advanced diagnostics and specialized medical treatments locally, significantly reducing the need for patients to travel outside the state for care.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Union Health Minister JP Nadda inaugurated ARHI Hospital in Ri-Bhoi, Meghalaya, highlighting central efforts to enhance advanced tertiary care in the region...
4 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today